Burzynski Antineoplastons
Synthetic peptides and amino acid derivatives that allegedly act as molecular switches to reprogram cancer cells.
61/100
Stanislaw Burzynski
Months to years (median 6-12 months intensive phase)
9 phases
2 targeted
Protocol Overview
Synthetic peptides and amino acid derivatives that allegedly act as molecular switches to reprogram cancer cells. Dr. Burzynski claims high success rates for brain tumors but treatments are controversial and expensive.
Key Resources
Safety Profile
FDA has allowed limited clinical trials but not approved. Very expensive and not covered by insurance. Many patients report bankrupting themselves. Mixed outcomes, publication bias concerns.
About Evidence Score
The Evidence Score rates the strength of clinical and scientific evidence behind this protocol. Higher scores indicate stronger research support. This is a research tool, not medical advice.
Educational purposes only. Some alternative protocols carry serious risks. Always consult qualified healthcare professionals before beginning any treatment.